1. Home
  2. SPTX vs CPAC Comparison

SPTX vs CPAC Comparison

Compare SPTX & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.25

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$11.46

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPTX
CPAC
Founded
N/A
1949
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2026
2003

Fundamental Metrics

Financial Performance
Metric
SPTX
CPAC
Price
$21.25
$11.46
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$12.90
AVG Volume (30 Days)
206.6K
108.6K
Earning Date
N/A
04-24-2026
Dividend Yield
N/A
5.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.49
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.78
Revenue Growth
N/A
N/A
52 Week Low
$17.59
$5.66
52 Week High
$22.98
$12.70

Technical Indicators

Market Signals
Indicator
SPTX
CPAC
Relative Strength Index (RSI) 62.35 48.94
Support Level $17.89 $10.30
Resistance Level $21.59 $12.70
Average True Range (ATR) 1.88 0.20
MACD 0.06 -0.08
Stochastic Oscillator 68.80 7.37

Price Performance

Historical Comparison
SPTX
CPAC

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company, and only cement manufacturer serving in the northern region of Peru. It produce, distribute and sell cement and cement-related materials, such as precast products and ready-mix concrete. Its products are mainly used in construction, which has been one of the fastest growing segments of the Peruvian economy in recent years. It also produce and sell quicklime for use in mining operations. It also provide transportation services. It has three operating segments cement, concrete, mortar, pavement and precast; quicklime; and sales of construction supplies. The majority of profit comes from Cement segment. Peru's cement production is into three regions northern region, central region, including Lima's metropolitan area, and southern region.

Share on Social Networks: